África García-Orad Carles-rekin lankidetzan egindako argitalpenak (71)

2021

  1. A Genome-Wide Study of Single-Nucleotide Polymorphisms in MicroRNAs and Further In Silico Analysis Reveals Their Putative Role in Susceptibility to Late-Onset Alzheimer’s Disease

    Molecular Neurobiology, Vol. 58, Núm. 1, pp. 55-64

2020

  1. Role of rs10406069 in miR-5196 in hyperdiploid childhood acute lymphoblastic leukemia

    Epigenomics, Vol. 12, Núm. 22, pp. 1949-1955

  2. Variability in Cerebrospinal Fluid MicroRNAs Through Life

    Molecular Neurobiology, Vol. 57, Núm. 10, pp. 4134-4142

2019

  1. A Systematic Review of MicroRNA Expression as Biomarker of Late-Onset Alzheimer’s Disease

    Molecular Neurobiology, Vol. 56, Núm. 12, pp. 8376-8391

  2. A comprehensive study of vesicular and non-vesicular miRNAs from a volume of cerebrospinal fluid compatible with clinical practice

    Theranostics, Vol. 9, Núm. 16, pp. 4567-4579

  3. An update on the implication of physical activity on semen quality: a systematic review and meta-analysis

    Archives of Gynecology and Obstetrics, Vol. 299, Núm. 4, pp. 901-921

  4. Cell-free DNA as a biomarker in diffuse large B-cell lymphoma: A systematic review

    Critical Reviews in Oncology/Hematology, Vol. 139, pp. 7-15

  5. Impact of polymorphisms in apoptosis-related genes on the outcome of childhood acute lymphoblastic leukaemia

    British Journal of Haematology

  6. MiRNA deregulation in childhood acute lymphoblastic leukemia: A systematic review

    Epigenomics, Vol. 12, Núm. 1, pp. 69-80

  7. Systematic review of the potential of MicroRNAs in diffuse large B cell lymphoma

    Cancers, Vol. 11, Núm. 2

  8. Variants in vincristine pharmacodynamic genes involved in neurotoxicity at induction phase in the therapy of pediatric acute lymphoblastic leukemia

    Pharmacogenomics Journal, Vol. 19, Núm. 6, pp. 564-569

2018

  1. Circulating miRNAs as biomarkers in diffuse large B-cell lymphoma: A systematic review

    Oncotarget, Vol. 9, Núm. 32, pp. 22850-22861

  2. Involvement of SNPs in miR-3117 and miR-3689d2 in childhood acute lymphoblastic leukemia risk

    Oncotarget, Vol. 9, Núm. 33, pp. 22907-22914

  3. Involvement of miRNA polymorphism in mucositis development in childhood acute lymphoblastic leukemia treatment

    Pharmacogenomics, Vol. 19, Núm. 18, pp. 1403-1412

  4. Mir-pharmacogenetics of Vincristine and peripheral neurotoxicity in childhood B-cell acute lymphoblastic leukemia

    Pharmacogenomics Journal, Vol. 18, Núm. 6, pp. 704-712

  5. Osteosarkoma pediatrikoarekiko suszeptibilitatean inplikatuta dauden aldaera genetikoak

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 34, pp. 59-82

  6. Pharmacoepigenetics in childhood acute lymphoblastic leukemia: Involvement of miRNA polymorphisms in hepatotoxicity

    Epigenomics, Vol. 10, Núm. 4, pp. 409-417

  7. Role of miRNAs in treatment response and toxicity of childhood acute lymphoblastic leukemia

    Pharmacogenomics, Vol. 19, Núm. 4, pp. 361-373

  8. Variants in the 14q32 miRNA cluster are associated with osteosarcoma risk in the Spanish population

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. Confirmation of involvement of new variants at CDKN2A/B in pediatric acute lymphoblastic leukemia susceptibility in the Spanish population

    PLoS ONE, Vol. 12, Núm. 5